Automated Compounding Devices Market Poised for Growth Amid Rising Chronic Disease Prevalence and Technological Advancements

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Automated Compounding Devices - Market Insights, Competitive Landscape, and Market Forecast - 2028" report has been added to's offering.

The global market for automated compounding devices is forecasted to experience significant growth, driven by the increasing need for precision in medication dispensing and the surge in personalized medicine. A comprehensive market analysis, focusing on the multifaceted developments in the field, reveals key insights and predicts a steady CAGR forecast till 2028.

The analysis highlights the various factors fueling market expansion, including the worldwide rise in chronic illnesses such as cancer and diabetes, and the critical need to prevent medication errors in healthcare settings. Innovations in automated compounding technology demonstrate the industry's commitment to enhancing pharmaceutical care and patient safety.

Key Market Dynamics

Automated compounding devices, pivotal in revolutionizing pharmacy operations, are gaining traction owing to their role in reducing human error and increasing efficiency in medication preparation. The devices ensure accurate dosages and sterility, decreasing the risk associated with manual compounding.

Technological Innovations Steering Growth:

Emerging technologies in volumetric and gravimetric systems are reshaping how pharmacies approach medication compounding. Notable advancements, such as enhanced cybersecurity measures in compounding equipment, reflect an industry poised for transformation.

Market Segmentation and Regional Dominance:

An in-depth segment analysis of the market reveals that volumetric automated compounding systems contribute significantly to industry revenues. Geographically, North America is at the forefront, with its advanced healthcare system and emphasis on reducing pharmacological errors leading the way.

Key Players and Recent Developments

  • Baxter, B.Braun SE, and other industry leaders are pivotal in driving advancements and adoption of automated compounding systems.
  • Recent developments include the launch of a new automated compounder that adheres to rigorous cybersecurity standards, indicating a focused direction towards safe and secure pharmaceutical practices.

Future Outlook

The automated compounding devices market is set for growth against the backdrop of a rising geriatric population and proliferating chronic diseases. The ongoing collaborative efforts of government bodies and key industry players are expected to further bolster market expansion.

Seamless integration of advanced compounding devices into healthcare systems is transforming the horizon of pharmaceutical care. The market report delves into the intricacies of these advancements, showcasing a future where precision and safety in medication compounding are paramount.

Target Audience Engagement

This exploration into the automated compounding devices market aims to empower various stakeholders, including healthcare providers, research institutions, policy framers, and end-users, with strategic insight into the market dynamics and future prospects.

The insightful findings projected in this market analysis are crucial for understanding the trajectory of the automated compounding devices sector and will guide informed decision-making across the healthcare and pharmaceutical landscape.

A selection of companies mentioned in this report includes

  • Baxter
  • B.Braun SE
  • COMECER S.p.A.
  • Icumedical
  • Grifols, S.A.
  • Omnicell, Inc.
  • BD
  • ARxUM
  • NewIcon
  • Loccioni
  • Fagron

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Contact Data